Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18630584 | METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY | April 2024 | August 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18595392 | LARGE-SCALE PRODUCTION OF MYCELIUM-BASED TEXTILES AT MUSHROOM FARM FACILITIES | March 2024 | May 2025 | Allow | 14 | 1 | 0 | Yes | No |
| 18419836 | ENZYME-ASSISTED ATRP PROCEDURES | January 2024 | April 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18524494 | BACTERIAL CULTURES AND METHODS FOR PRODUCTION OF ALGINATE | November 2023 | March 2025 | Allow | 15 | 1 | 1 | Yes | No |
| 18523358 | METHODS OF PROCESSING LIGNOCELLULOSIC BIOMASS USING SINGLE-STAGE AUTOHYDROLYSIS AND ENZYMATIC HYDROLYSIS WITH C5 BYPASS AND POST-HYDROLYSIS | November 2023 | May 2025 | Allow | 18 | 1 | 0 | No | No |
| 18520265 | TISSUE PRESERVATION SYSTEM | November 2023 | December 2024 | Abandon | 13 | 1 | 0 | No | No |
| 18558863 | A Bioreactor and Process for Forming Polyhydroxybutyrate Directly from Depolymerized Polyhydroxybutyrate | November 2023 | June 2025 | Allow | 19 | 1 | 1 | Yes | No |
| 18382410 | SYSTEM FOR GROWING FUNGAL MATERIALS | October 2023 | April 2025 | Abandon | 18 | 1 | 1 | No | No |
| 18371651 | COMPOSITIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | September 2023 | June 2025 | Allow | 21 | 1 | 1 | Yes | No |
| 18455533 | CELLULOSE NANOFIBRILLAR BIOINK FOR 3D BIOPRINTING FOR CELL CULTURING, TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS | August 2023 | February 2025 | Abandon | 18 | 0 | 1 | No | No |
| 18220535 | METHODS TO GENERATE POLYMER SCAFFOLDS HAVING A GRADIENT OF CROSSLINKING DENSITY | July 2023 | May 2025 | Abandon | 22 | 2 | 1 | No | No |
| 18341692 | METHODS OF PREPARING T CELLS FOR T CELL THERAPY | June 2023 | February 2025 | Abandon | 20 | 2 | 0 | Yes | No |
| 18319085 | METHOD OF PRODUCING THIN ENZYME-BASED SENSING LAYERS ON PLANAR SENSORS | May 2023 | December 2023 | Allow | 7 | 0 | 0 | Yes | No |
| 18177070 | SIALYLTRANSFERASES FOR IN VIVO SYNTHESIS OF 3'SL | March 2023 | August 2024 | Allow | 18 | 1 | 1 | No | No |
| 18166412 | METHOD FOR STABILIZATION AND DELIVERY OF THERAPEUTIC MOLECULES | February 2023 | September 2024 | Allow | 19 | 3 | 0 | Yes | No |
| 18162957 | CONTROLLED OUTGASSING OF HYPERBARICALLY LOADED MATERIALS FOR THE DELIVERY OF OXYGEN AND OTHER THERAPEUTIC GASES IN BIOMEDICAL APPLICATIONS | February 2023 | September 2024 | Allow | 19 | 1 | 0 | Yes | No |
| 18104578 | METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY | February 2023 | January 2024 | Allow | 11 | 0 | 0 | Yes | No |
| 18097755 | OPEN-TOP MICROFLUIDIC DEVICE WITH STRUCTURAL ANCHORS | January 2023 | July 2023 | Allow | 6 | 0 | 1 | Yes | No |
| 17993690 | SATELLITE CELLS AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | November 2022 | February 2023 | Allow | 3 | 0 | 0 | Yes | No |
| 18058042 | MECHANISM BASED QUALITY CONTROL FOR BOTANICAL MEDICINE | November 2022 | October 2023 | Allow | 10 | 0 | 0 | Yes | No |
| 17967598 | TISSUE PRESERVATION SYSTEM | October 2022 | August 2023 | Allow | 10 | 1 | 0 | Yes | No |
| 17995367 | METHOD FOR PRODUCING SULFATED POLYSACCHARIDE AND METHOD FOR PRODUCING PAPS | October 2022 | November 2024 | Allow | 26 | 3 | 0 | Yes | No |
| 17937553 | USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH | October 2022 | January 2023 | Allow | 3 | 0 | 0 | Yes | No |
| 17937554 | USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH | October 2022 | January 2023 | Allow | 3 | 0 | 0 | Yes | No |
| 17934119 | METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY | September 2022 | January 2023 | Allow | 3 | 0 | 0 | Yes | No |
| 17942952 | ENZYME-ASSISTED ATRP PROCEDURES | September 2022 | October 2023 | Allow | 13 | 1 | 0 | Yes | No |
| 17864154 | PROCESS FOR TREATING WATERS, SOILS, SEDIMENTS AND/OR SLUDGES | July 2022 | March 2025 | Allow | 32 | 3 | 1 | Yes | No |
| 17778201 | METHOD FOR PRODUCING 3,5-DIHYDROXY-4-METHOXYBENZYL ALCOHOL FROM PLANKTON | May 2022 | February 2025 | Allow | 33 | 1 | 0 | No | No |
| 17737424 | METHOD FOR STABILIZATION AND DELIVERY OF THERAPEUTIC MOLECULES | May 2022 | November 2022 | Allow | 6 | 0 | 0 | Yes | No |
| 17733531 | METHODS FOR DETECTION, DETERMINATION, AND ACTIVITY MEASUREMENT OF PEROXIDASE BASED ON CHEMILUMINESCENCE | April 2022 | September 2023 | Allow | 16 | 1 | 0 | No | No |
| 17728480 | SYSTEM FOR GROWING FUNGAL MATERIALS | April 2022 | September 2023 | Allow | 17 | 1 | 0 | Yes | No |
| 17765548 | Methods for Isolating Single-Molecule Products | March 2022 | July 2024 | Abandon | 27 | 1 | 1 | No | No |
| 17763761 | PROCESSES AND SYSTEMS FOR BIOLOGICAL HYDROGEN PRODUCTION FROM ORGANIC WASTE USING YEAST | March 2022 | September 2024 | Allow | 30 | 1 | 0 | Yes | No |
| 17753324 | ACTIVITY BASED PROBES | February 2022 | March 2025 | Allow | 36 | 1 | 1 | Yes | No |
| 17674913 | Oleaginous Yeast and its application | February 2022 | September 2024 | Allow | 31 | 1 | 0 | No | No |
| 17671262 | MICROBIAL COMPOSITIONS AND METHODS | February 2022 | January 2024 | Allow | 23 | 0 | 0 | Yes | No |
| 17671479 | ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS FOR USE IN TREATING REFRACTORY COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE | February 2022 | September 2024 | Allow | 31 | 3 | 0 | Yes | No |
| 17634162 | Production of Fatty Acid Esters Using a Yeast Culture | February 2022 | October 2024 | Abandon | 32 | 0 | 1 | No | No |
| 17583067 | PapQuin-50 a Quinoa grain-based bacterial growth medium nitrogen source | January 2022 | November 2023 | Allow | 21 | 0 | 1 | Yes | No |
| 17571555 | HEALTH FOOD FOR PROMOTION OF QUALITY OF SLEEPY AND METABOLISM | January 2022 | March 2024 | Abandon | 26 | 1 | 0 | No | No |
| 17621121 | OPTIMIZED BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF LEUCINE, ISOLEUCINE, AND/OR VALINE | December 2021 | June 2025 | Abandon | 42 | 0 | 1 | No | No |
| 17556966 | COMPOSITIONS AND METHODS FOR PRODUCING 1,8-DIHYDROXYNAPHTHALENE AND CYCLIC HYDROCARBONS FROM 1,8-DIHYDROXYNAPHTHALENE | December 2021 | April 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17551221 | METHOD FOR EXTRACTING FUNCTIONAL INGREDIENTS OF MULBERRY LEAVES USING ENZYMES | December 2021 | February 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17618668 | METHOD FOR THE PRODUCTION OF IODINATED PROTEINS WITH A DETERMINATED IODINE CONTENT | December 2021 | September 2024 | Allow | 33 | 0 | 1 | Yes | No |
| 17617527 | ENGINEERED ACETATE KINASE VARIANT ENZYMES | December 2021 | December 2024 | Allow | 36 | 1 | 1 | No | No |
| 17615342 | THERMOSTABLE GLUCOSE OXIDASE | November 2021 | September 2024 | Allow | 34 | 1 | 1 | No | No |
| 17615160 | Method of Recovering a Protein from Fermentation Broth Using a Divalent Cation | November 2021 | August 2024 | Allow | 33 | 1 | 0 | Yes | No |
| 17614106 | METHOD FOR THE PRODUCTION OF BIOGAS | November 2021 | March 2024 | Allow | 27 | 1 | 0 | Yes | No |
| 17611109 | NANORG MICROBIAL FACTORIES: LIGHT-DRIVEN RENEWABLE BIOCHEMICAL SYNTHESIS USING QUANTUM DOT-BACTERIA NANO-BIOHYBRIDS | November 2021 | April 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17525715 | Biological and Chemical Process Utilizing Chemoautotrophic Microorganisms for the Chemosynthetic Fixation of Carbon Dioxide and/or Other Inorganic Carbon Sources into Organic Compounds and the Generation of Additional Useful Products | November 2021 | March 2025 | Abandon | 40 | 3 | 0 | No | No |
| 17595093 | PURIFIED FISH PROTEASES WITH HIGH SPECIFIC ACTIVITIES AND ITS PROCESS OF PRODUCTION | November 2021 | February 2025 | Allow | 39 | 1 | 1 | Yes | No |
| 17508361 | ORAL REHYDRATION COMPOSITION WITH OLIGOSACCHARIDES | October 2021 | February 2024 | Abandon | 28 | 2 | 0 | No | No |
| 17605993 | IN VIVO IMMOBILIZATION OF PROTEINS | October 2021 | April 2025 | Allow | 42 | 2 | 1 | Yes | No |
| 17504858 | CONTINUOUS FLOW METHOD FOR PREPARING (R)-3-HYDROXY-5-HEXENOATE | October 2021 | September 2023 | Allow | 23 | 0 | 1 | Yes | No |
| 17502445 | USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH | October 2021 | September 2022 | Allow | 11 | 2 | 0 | Yes | No |
| 17600767 | Process For Producing A Fermentation Product | October 2021 | October 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17601045 | MUT- METHYLOTROPHIC YEAST | October 2021 | December 2024 | Allow | 39 | 1 | 0 | No | No |
| 17436512 | LANTIBIOTICS AND LANTIBIOTIC-PRODUCING BACTERIA | September 2021 | January 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17435530 | LIPID BIOSYNTHESIS AND ABIOTIC STRESS RESILIENCE IN PHOTOSYNTHETIC ORGANISMS | September 2021 | March 2025 | Abandon | 42 | 2 | 1 | No | No |
| 17458929 | ASPARAGINE FEED STRATEGIES TO IMPROVE CELL CULTURE PERFORMANCE AND MITIGATE ASPARAGINE SEQUENCE VARIANTS | August 2021 | August 2024 | Allow | 35 | 2 | 1 | Yes | No |
| 17432500 | MODIFIED MICROORGANISMS EXPRESSING SAGA AND RELATED COMPOSITIONS FOR IMMUNOMODULATION AGAINST INFECTION AND CANCER IMMUNOTHERAPY | August 2021 | December 2024 | Allow | 40 | 1 | 1 | Yes | No |
| 17430328 | GENE FOR TRYPSIN-LIKE SERINE PROTEASE, A PROTEIN ENCODED THEREBY AND USE THEREOF | August 2021 | May 2024 | Allow | 33 | 1 | 0 | No | No |
| 17429773 | Novel Methods for Production of Mannosylerythritol Lipids | August 2021 | May 2023 | Allow | 22 | 0 | 0 | Yes | No |
| 17425261 | SUPERNEGATIVELY CHARGED PROTEINS AND USES THEREOF | July 2021 | February 2025 | Allow | 43 | 2 | 1 | Yes | No |
| 17380226 | NANOREACTOR USING POLYION COMPLEX POLYMERSOMES, AND METHOD FOR PRODUCING SAME | July 2021 | December 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17375551 | SCHIZOCHYTRIUM STRAIN AND USE THEREOF, MICROBIAL OIL CONTAINING DHA AT SN-2 POSITION AND PREPARATION AND USE THEREOF | July 2021 | January 2025 | Allow | 42 | 2 | 1 | Yes | No |
| 17374966 | SUPERFLUIDS DISRUPTION OF SACCHAROMYCES CEREVISIAE (YEAST), CELL WALL DISINTEGRATION INTO NANOPARTICLES AND FRACTIONATION INTO BETA-GLUCANS, CHITIN AND MANNANS (MANNOPROTEINS) | July 2021 | April 2025 | Abandon | 46 | 2 | 1 | No | No |
| 17372372 | PROCESS FOR REDUCING THE ACTIVITY OF MICROBIAL CONTAMINATION IN A YEAST MEDIUM | July 2021 | July 2025 | Allow | 48 | 3 | 1 | Yes | No |
| 17419122 | PICHIA PASTORIS MUTANT STRAIN FOR EXPRESSING EXOGENOUS GENE | June 2021 | December 2024 | Allow | 42 | 1 | 1 | No | No |
| 17350366 | METHOD OF SCREENING ATP11C OR CDC50A INHIBITOR | June 2021 | April 2023 | Allow | 22 | 1 | 0 | Yes | No |
| 17347793 | Do-it-Yourself Kit for the detection of E. coli and total coliform in water | June 2021 | May 2024 | Abandon | 36 | 1 | 1 | No | No |
| 17345660 | DEPHOSPHORYLATED LYSOSOMAL STORAGE DISEASE PROTEINS AND METHODS OF USE THEREOF | June 2021 | September 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17343501 | Processes, methods and rationale for manufacturing pre- probiotic dietary supplements aimed at protecting the human body from the harmful effects of electromagnetic radiations through quantum entanglement of DNA repair genes elicited by natural superluminal particles inducing photosynthesis via Cherenkov effect | June 2021 | February 2024 | Allow | 32 | 1 | 1 | Yes | No |
| 17299809 | METHOD OF PRODUCING FUNGAL MATS AND MATERIALS MADE THEREFROM | June 2021 | December 2024 | Allow | 43 | 2 | 1 | Yes | No |
| 17309448 | METHOD FOR PRODUCING YEAST CONTAINING RICH-TASTE-IMPARTING SUBSTANCE AND METHOD FOR PRODUCING YEAST EXTRACT CONTAINING RICH-TASTE-IMPARTING SUBSTANCE | May 2021 | June 2024 | Allow | 37 | 1 | 0 | Yes | No |
| 17329960 | METHODS OF PROCESSING LIGNOCELLULOSIC BIOMASS USING SINGLE-STAGE AUTOHYDROLYSIS AND ENZYMATIC HYDROLYSIS WITH C5 BYPASS AND POST-HYDROLYSIS | May 2021 | August 2023 | Allow | 27 | 2 | 0 | Yes | No |
| 17326742 | SYSTEM FOR GROWING FUNGAL MATERIALS | May 2021 | March 2022 | Allow | 10 | 1 | 0 | Yes | No |
| 17293832 | GLYCOGEN-NULL METHANOTROPHS AND USES THEREOF | May 2021 | October 2024 | Allow | 41 | 1 | 1 | Yes | No |
| 17314930 | METHOD OF PRODUCING THIN ENZYME-BASED SENSING LAYERS ON PLANAR SENSORS | May 2021 | March 2023 | Allow | 22 | 0 | 0 | Yes | No |
| 17306189 | CO2 SEQUESTRATION AND CREATION OF CALCIUM CARBONATES THROUGH MICROBIAL INDUCED CARBONATE PRECIPITATION | May 2021 | March 2024 | Allow | 35 | 2 | 1 | Yes | No |
| 17286669 | METHOD FOR PREPARING ORGANIC MOLECULES BY ANAEROBIC FERMENTATION | April 2021 | June 2023 | Allow | 26 | 1 | 0 | Yes | No |
| 17230155 | METHOD FOR PRODUCING CIS-UNSATURATED FATTY ACID BY RECOMBINANT CANDIDA RUGOSA LIPASE 1 (rCRL1) | April 2021 | April 2023 | Allow | 24 | 1 | 0 | Yes | No |
| 17226333 | MITOCHONDRIA ISOLATION | April 2021 | September 2023 | Allow | 29 | 1 | 1 | Yes | No |
| 17282857 | LACTOCOCCUS LACTIS EXPRESSION SYSTEM FOR DELIVERING PROTEINS EFFICACIOUS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS | April 2021 | January 2025 | Abandon | 46 | 1 | 1 | No | No |
| 16627710 | DIRECT DETECTION OF THE ACTIVE FORM OF BETA-LACTAM-HYDROLYSING ENZYMES BY USING MASS SPECTROPHOTOMETRY | March 2021 | December 2021 | Allow | 24 | 0 | 0 | Yes | No |
| 17204432 | METHODS AND COMPOSITION FOR CONTROLLING MAP INFECTION AND CONTAMINATION | March 2021 | November 2024 | Abandon | 44 | 1 | 1 | No | No |
| 17203491 | MICROBIAL SOIL ENHANCEMENT | March 2021 | July 2023 | Abandon | 28 | 2 | 1 | No | No |
| 17267028 | COMPOSITION FOR INHIBITING FCERI EXPRESSION AND METHOD FOR INHIBITING FCERI EXPRESSION | February 2021 | March 2025 | Abandon | 49 | 2 | 1 | No | No |
| 17160617 | OPEN-TOP MICROFLUIDIC DEVICE WITH STRUCTURAL ANCHORS | January 2021 | September 2021 | Allow | 8 | 0 | 1 | Yes | No |
| 17139245 | IMMOBILIZED ENZYME FOR DIRECTIONALLY CATALYZING ESTERIFICATION REACTION AND PREPARATION METHOD AND USE THEREOF | December 2020 | August 2022 | Abandon | 20 | 0 | 1 | No | No |
| 17125322 | Methods of Making Spheroids Including Biologically-Relevant Materials | December 2020 | October 2023 | Allow | 33 | 2 | 0 | Yes | No |
| 17253266 | LIPOLYTIC ENZYME VARIANTS | December 2020 | August 2024 | Allow | 44 | 1 | 1 | Yes | No |
| 17252676 | METHYL SULFONYL METHANE-CONTAINING COMPOSITION FOR PREVENTING OR ALLEVIATING OBESITY, FATTY LIVER, AND DIABETES | December 2020 | April 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17059928 | COMPOSTIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | November 2020 | November 2023 | Abandon | 36 | 1 | 1 | No | No |
| 16950719 | BIOLOGICAL INDICATOR FOR RAPID VERIFICATION OF DISINFECTION OR STERILIZATION | November 2020 | June 2023 | Abandon | 31 | 0 | 1 | No | No |
| 17081745 | SYSTEM FOR GROWING FUNGAL MATERIALS | October 2020 | April 2021 | Allow | 6 | 0 | 0 | Yes | No |
| 17077581 | DETECTION OF BETA-HEMOLYTIC PATHOGENS | October 2020 | January 2023 | Allow | 27 | 0 | 0 | Yes | No |
| 17036110 | METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY | September 2020 | September 2022 | Allow | 24 | 0 | 0 | Yes | No |
| 16980198 | BACTERIAL CULTURES AND METHODS FOR PRODUCTION OF ALGINATE | September 2020 | August 2023 | Allow | 36 | 2 | 1 | Yes | No |
| 16772578 | CELL PROLIFERATION INHIBITOR AND CANCER TREATMENT OR PREVENTION PHARMACEUTICAL COMPOSITION INCLUDING CELL PROLIFERATION INHIBITOR | August 2020 | March 2024 | Abandon | 45 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SINGH, SATYENDRA K.
With a 35.7% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 31.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SINGH, SATYENDRA K works in Art Unit 1657 and has examined 701 patent applications in our dataset. With an allowance rate of 61.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.
Examiner SINGH, SATYENDRA K's allowance rate of 61.8% places them in the 15% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SINGH, SATYENDRA K receive 1.97 office actions before reaching final disposition. This places the examiner in the 64% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by SINGH, SATYENDRA K is 36 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +73.7% benefit to allowance rate for applications examined by SINGH, SATYENDRA K. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 24.3% of applications are subsequently allowed. This success rate is in the 26% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 22.6% of cases where such amendments are filed. This entry rate is in the 21% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 54.5% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 45% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 64.1% of appeals filed. This is in the 38% percentile among all examiners. Of these withdrawals, 64.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 48.1% are granted (fully or in part). This grant rate is in the 56% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 7.0% of allowed cases (in the 93% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.